Anal carcinoma
Therapeutic area
Oncology
Rare disease
No
- Definition
- A carcinoma that arises from epithelial cells of the anus
- Genetic basis
- No
- Non-human condition
- No
- Rare disease
- No
- Listing at source
- Listed
- Condition name
- Anal carcinoma
- Therapeutic area
- Oncology
- anal carcinoma
- Ca anus
- anal cancer
- cancer of anus
- cancer of the anus
- anal carcinoma
- anus carcinoma
- carcinoma of anus
- carcinoma of the anus
- Severity
- Severe
- Gastroenterology
- Oncology
- MONDO ID
- MONDO:0003199
- Parent condition
- MONDO:0001879
Related records
Broader conditions (29)
- Anus cancer
- Anus disorder
- Anus neoplasm
- Cancer
- Cancer or benign tumor
- Carcinoma
- Colorectal cancer
- Colorectal carcinoma
- Colorectal neoplasm
- Digestive system cancer
- Digestive system carcinoma
- Digestive system disorder
- Digestive system neoplasm
- Disease
- Disease by body system or component
- Disease by etiologic mechanism
- Epithelial neoplasm
- Epithelial neoplasm of rectum
- Human disease
- Intestinal cancer
Narrower conditions (19)
- Anal canal adenocarcinoma
- Anal canal carcinoma
- Anal canal carcinoma in situ
- Anal canal neuroendocrine neoplasm
- Anal canal Paget disease
- Anal canal squamous cell carcinoma
- Anal gland adenocarcinoma
- Anal margin basal cell carcinoma
- Anal margin carcinoma
- Anal margin squamous cell carcinoma
- Anal mucinous adenocarcinoma
- Anal Paget disease
- Anal squamous cell carcinoma
- Anal verrucous carcinoma
- Anus adenocarcinoma
- Anus basaloid carcinoma
- Cloacogenic carcinoma
- Neuroendocrine tumor of the anal canal
- Perianal skin Paget disease
Trials (193)
- 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)
- A Chatbot Intervention for Reducing HPV Vaccine Hesitancy
- A Message Framing Intervention for Increasing Parental Acceptance of Human Papillomavirus Vaccination
- A Multilevel Intervention to Improve Timely Cancer Detection and Treatment Initiation
- A Phase 2 Study of Axalimogene Filolisbac (ADXS11-001) in Participants With Carcinoma of the Anorectal Canal
- A Phase I/II Evaluation of ADXS11-001, Mitomycin, 5-fluorouracil (5-FU) and IMRT for Anal Cancer
- A Phase I/II Study of Combination Immunotherapy for Advanced Cancers Including HPV-Associated Malignancies, Small Bowel, and Colon Cancers
- A Phase III Study to Evaluate the Efficacy, Immunogenicity and Safety of the 9-valent HPV Vaccine in Chinese Males
- A Phase III Trial to Evaluate the Efficacy, Immunogenicity and Safety of a Recombinant Human Papillomavirus 9-Valent (Types 6, 11, 16, 18, 31, 33, 45, 52, 58) Vaccine (E.Coli) in Chinese Males
- A Prospective, Open-Label, Multi-center Comparison of Lymphoseek Identified Lymph Nodes and Clinically Identified Lymph Nodes of Subjects With Known Cancer of the Anus
- A Safety and Efficacy Trial of Circumferential Anal Canal Radiofrequency Ablation for High-Grade Anal Intraepithelial Neoplasia Using the BARRX™ Anorectal Wand
- A Study in Advanced or Metastatic Gastrointestinal Cancers Exploring Treatment Combinations With Pelareorep and Atezolizumab
- A Study of mDCF in Combination or Not With Atezolizumab in Advanced Squamous Cell Anal Carcinoma
- A Study of Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced Cancers
- A Study of Vobramitamab Duocarmazine in Participants With Metastatic Castration Resistant Prostate Cancer and Other Solid Tumors
- A Study Regarding Tissue Response During and After Treatment for Anal Cancer
- Anal Cancer and/or Precancer Screening: Performance Analysis of the BD Onclarity™ HPV Assay on Anal Specimens
- Anal Cancer Radiotherapy Study
- Anal Cancer Risk In Women
- Anal Cancer Screening Study
Drugs in development (4)
- Durvalumab Phase 2
- Fluorouracil Phase 3
- Mitomycin Phase 3
- Pembrolizumab Phase 2